Search Orphan Drug Designations and Approvals
-
Generic Name: | 5-{[(3R,4R)-1-(4-chloro-2,6-difluorophenyl)-3,4-dihydroxypiperidin-4-yl]methoxy}-8-fluoro-3,4-dihydroquinolin-2(1H)-one |
---|---|
Date Designated: | 12/05/2016 |
Orphan Designation: | Treatment of active tuberculosis |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Otsuka Pharmaceutical Company, Ltd 2-9, Kanda-Tsukasamachi Tokyo Japan The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-